Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

50,321 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and safety of zimberelimab (GLS-010) monotherapy in patients with recurrent or metastatic cervical cancer: a multicenter, single-arm, phase II study.
Xia L, Wang J, Wang C, Zhang Q, Zhu J, Rao Q, Cheng H, Liu Z, Yin Y, Ai X, Gulina K, Zheng H, Luo X, Chang B, Li L, Liu H, Li Y, Lou G, Zhou Q, Zhu Y, Xiao Z, Tong J, Wang K, Chen J, Wang X, Song L, Wei Z, Ye Y, Zhu J, Wu X. Xia L, et al. Among authors: zhu y, zhu j. Int J Gynecol Cancer. 2023 Dec 4;33(12):1861-1868. doi: 10.1136/ijgc-2023-004705. Int J Gynecol Cancer. 2023. PMID: 37875323 Free PMC article. Clinical Trial.
Efficacy and Safety of Anlotinib in Overall and Disease-Specific Advanced Gynecological Cancer: A Real-World Study.
Hong X, Qiu S, Wu X, Chen S, Chen X, Zhang B, He A, Xu Y, Wang J, Gao Y, Xu X, Sun L, Zhang Y, Xiang L, Zhou J, Guan Q, Zhu Y, Liu H, Xu H, Zhou Y, Chen B, Shen Y. Hong X, et al. Among authors: zhu y. Drug Des Devel Ther. 2023 Jul 6;17:2025-2033. doi: 10.2147/DDDT.S408304. eCollection 2023. Drug Des Devel Ther. 2023. PMID: 37435095 Free PMC article.
Efficacy and Safety of Niraparib as First-Line Maintenance Treatment for Patients with Advanced Ovarian Cancer: Real-World Data from a Multicenter Study in China.
Zhao M, Qiu S, Wu X, Miao P, Jiang Z, Zhu T, Xu X, Zhu Y, Zhang B, Yuan D, Zhang Y, Sun W, He A, Zhao M, Hou W, Zhang Y, Shao Z, Jia M, Li M, Chen J, Xu J, Chen B, Zhou Y, Shen Y. Zhao M, et al. Among authors: zhu t, zhu y. Target Oncol. 2023 Nov;18(6):869-883. doi: 10.1007/s11523-023-00999-x. Epub 2023 Oct 17. Target Oncol. 2023. PMID: 37847485 Free PMC article.
Stem cell-like memory T cells: A perspective from the dark side.
Gao S, Liang X, Wang H, Bao B, Zhang K, Zhu Y, Shao Q. Gao S, et al. Among authors: zhu y. Cell Immunol. 2021 Mar;361:104273. doi: 10.1016/j.cellimm.2020.104273. Epub 2021 Jan 5. Cell Immunol. 2021. PMID: 33422699 Review.
50,321 results
You have reached the last available page of results. Please see the User Guide for more information.